J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 548, Number 3, 893-906, May 1, 2003 DOI: 10.1113/jphysiol.2002.034116
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
548/3/893    most recent
2002.034116v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Itoh, T.
Right arrow Articles by Mabuchi, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Itoh, T.
Right arrow Articles by Mabuchi, Y.
J Physiol (2003), 548.3, pp. 893-906
© Copyright 2003 D 2003 The Physiological Society
DOI: 10.1113/jphysiol.2002.034116

Angiotensin II-induced modulation of endothelium-dependent relaxation in rabbit mesenteric resistance arteries

Takeo Itoh*, Junko Kajikuri*, Toyohiro Tada†, Yoshikatsu Suzuki‡ and Yoshio Mabuchi§

Departments of *Cellular and Molecular Pharmacology, ‡Obstetrics and Gynecology and §Functional Morphology, Graduate School of Medical Sciences, Nagoya City University and †Department of Pathology, Nagoya City University School of Nursing, Nagoya 467-8601, Japan

The role of local endogenous angiotensin II (Ang II) in endothelial function in resistance arteries was investigated using rabbit mesenteric resistance arteries. First, the presence of immunoreactive Ang II together with Ang II type-1 receptor (AT1R) and angiotensin converting enzyme (ACE) was confirmed in these arteries. In endothelium-intact strips, the AT1R-blocker olmesartan (1 µM) and the ACE-inhibitor temocaprilat (1 µM) each enhanced the ACh (0.03 µM)-induced relaxation during the contraction induced by noradrenaline (NA, 10 µM). Similar effects were obtained using CV-11974 (another AT1R blocker) and enalaprilat (another ACE inhibitor). The nitric-oxide-synthase inhibitor NG-nitro-L-arginine (L-NNA) abolished the above effect of olmesartan. In endothelium-denuded strips, olmesartan enhanced the relaxation induced by the NO donor NOC-7 (10 nM). Olmesartan had no effect on cGMP production (1) in endothelium-intact strips (in the absence or presence of ACh) or (2) in endothelium-denuded strips (in the absence or presence of NOC-7). In beta-escin-skinned strips, 8-bromoguanosine 3',5' cyclic monophosphate (8-Br-cGMP, 0.01-1 µM) concentration dependently inhibited the contractions induced (a) by 0.3 µM Ca2+ in the presence of NA+GTP and (b) by 0.2 µM Ca2++GTPgammaS. Olmesartan significantly enhanced, while Ang II (0.1 nM) significantly inhibited, the 8-Br-cGMP-induced relaxation. We propose the novel hypothesis that in these arteries, Ang II localized within smooth muscle cells activates AT1Rs and inhibits ACh-induced, endothelium-dependent relaxation at least partly by inhibiting the action of cGMP on these cells.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 The Physiological Society.